Always Remember - Buy The Dip

Sentiment Analysis For ITCI

The news is currently generally neutral for ITCI.

Based on TextBlob analysis of Yahoo! Finance news summaries for ITCI on 2015-08-19.

Yahoo! Finance News for ITCI

Health Care Sector Update for 08/06/2015: OREX, MGNX, ITCI
Top Health care stocks JNJ 1.2% PFE 1.8% ABT flat MRK 1.1% AMGN 3.8% Health care shares were lower late Thursday. In health care stocks news, Orexigen Therapeutics ( OREX ) shares gained after announcing amended and restated its

Use Options For a Chance To Buy ITCI at a 69% Discount
Looking back to 154 days ago, Intra Cellular Therapies Inc (Symbol ITCI) priced a 4,750,000 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would

Intra-Cellular Reports Phase 3 Clinical Development Program In Bipolar Disorder
Intra-Cellular Reports Phase 3 Clinical Development Program In Bipolar Disorder

Use Options For a Chance To Buy ITCI at a 46% Discount
Looking back to 125 days ago, Intra Cellular Therapies Inc (Symbol ITCI) priced a 4,750,000 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would

AERI Rockets On FDA Feedback, ADXS On The Job, APRI To Report Trial Data In Q3
AERI Rockets On FDA Feedback, ADXS On The Job, APRI To Report Trial Data In Q3

AERI Rockets On FDA Feedback, ADXS On The Job, ITCI To Report Trial Data In Q3
AERI Rockets On FDA Feedback, ADXS On The Job, ITCI To Report Trial Data In Q3

AERI Rockets On FDA Feedback, ADXS On The Job, ITCI To Report Trial Data In Q3
AERI Rockets On FDA Feedback, ADXS On The Job, ITCI To Report Trial Data In Q3

Is Intra-Cellular Therapies (ITCI) Stock a Solid Choice Right Now? - Tale of the Tape
One stock that might be an intriguing choice for investors right now is Intra Cellular Therapies, Inc. ( ITCI ). This is because this security in the Medical Biomed Genetics space is seeing solid earnings estimate revision activity, and

Health Care Sector Update for 03/04/2015: INSY, EBIO, ITCI
Top Health Care Shares JNJ 0.2% PFE +0.1% ABT flat MRK 0.2% AMGN 0.1% Health care shares were mixed ahead of the opening bell Wednesday. In health care stocks news, Insys Therapeutics ( INSY ) saw its price target

Intra-Cellular Therapies (ITCI) Jumps: Stock Up 11.1% - Tale of the Tape
Intra Cellular Therapies, Inc. ( ITCI ) was a big mover last session with its shares rising over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal

Intra-Cellular Therapies (ITCI) Jumps: Stock Gains 12.2% - Tale of the Tape
Intra Cellular Therapies, Inc. ( ITCI ) was a big mover last session with its shares rising over 12% on the day. The move came on solid volume with far more shares changing hands than in a normal session.

Intra-Cellular Therapies (ITCI) Jumps: Stock Rises 6.8% - Tale of the Tape
Intra Cellular Therapies, Inc. ( ITCI ) was a big mover last session with its shares rising nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal

Intra-Cellular Commences Phase III Schizophrenia Study - Analyst Blog
Intra Cellular Therapies, Inc. ( ITCI ) announced that it has enrolled the first patient in a randomized, double blind, placebo controlled phase III study (ITI 007 301) on its lead candidate, ITI 007, for the treatment of schizophrenia.

Friday 11/7 Insider Buying Report: ITCI, CMRX
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard earned cash to make a

Intra-Cellular Therapies Reveals Top-line Data on ITI-007 - Analyst Blog
I ntra Cellular Therapies, Inc. 's ( ITCI ) shares gained 2.6% immediately after the company announced top line results from a phase I II study (ITI 007 200) on the company's lead candidate, ITI 007. However, shares fell

How Intra-Cellular Therapies (ITCI) Stock Stands Out in a Strong Industry - Tale of the Tape
One stock that might be an intriguing choice for investors right now is Intra Cellular Therapies, Inc. ( ITCI ). This is because this security in the Pharmaceutical industry space is seeing solid earnings estimate revision activity, and is

Intra-Cellular Therapies, Inc. (ITCI) in Focus: Stock Rises 8.74% - Tale of the Tape
Intra Cellular Therapies, Inc. ( ITCI ) was a big mover last session, as the company saw its shares rise nearly 9% on the day. This rally higher can be attributable to solid volume with far more shares changing

Neurological disorder biotech Intra-Cellular Therapies files for a $115 million IPO
Intra Cellular Therapies, a clinical stage biotech developing treatments for neurological disorders, filed on Friday with the SEC to raise up to $115 million in an initial public offering. The New York, NY based company, which was